Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2571) 2571
Newsletter (145) 145
Newspaper Article (41) 41
Magazine Article (11) 11
Book Chapter (8) 8
Dissertation (7) 7
Web Resource (3) 3
Publication (2) 2
Book Review (1) 1
Conference Proceeding (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tazobactam (1824) 1824
science & technology (1355) 1355
life sciences & biomedicine (1283) 1283
humans (983) 983
piperacillin (695) 695
penicillanic acid - analogs & derivatives (651) 651
infectious diseases (639) 639
antibiotics (631) 631
microbiology (605) 605
pharmacology & pharmacy (541) 541
male (509) 509
female (468) 468
microbial sensitivity tests (377) 377
piperacillin-tazobactam (373) 373
anti-bacterial agents - therapeutic use (357) 357
biological and medical sciences (348) 348
middle aged (348) 348
drug resistance (340) 340
medical sciences (329) 329
research (328) 328
health aspects (326) 326
anti-bacterial agents - pharmacology (314) 314
bacteria (301) 301
penicillanic acid - pharmacology (301) 301
patients (298) 298
aged (293) 293
pseudomonas aeruginosa (292) 292
antibacterial agents (288) 288
pharmacology. drug treatments (279) 279
infections (278) 278
adult (272) 272
hospitals (267) 267
drug resistance in microorganisms (253) 253
penicillanic acid - therapeutic use (253) 253
antibiotics. antiinfectious agents. antiparasitic agents (243) 243
piperacillin/tazobactam (240) 240
antimicrobial agents (234) 234
piperacillin - therapeutic use (233) 233
meropenem (229) 229
piperacillin - pharmacology (217) 217
beta-lactamase inhibitors (216) 216
analysis (209) 209
imipenem (209) 209
medical research (209) 209
pneumonia (203) 203
mortality (202) 202
sulbactam (198) 198
physical fitness (194) 194
vancomycin (194) 194
medicine, experimental (193) 193
anti-bacterial agents - administration & dosage (191) 191
care and treatment (188) 188
beta lactamases (183) 183
infection (183) 183
polycyclic compounds (182) 182
ceftazidime (181) 181
cefepime (169) 169
risk factors (168) 168
biochemical phenomena, metabolism, and nutrition (166) 166
treatment outcome (166) 166
penicillanic acid - administration & dosage (165) 165
pathogens (164) 164
e coli (163) 163
pseudomonas aeruginosa - drug effects (161) 161
piperacillin - administration & dosage (159) 159
bacterial infections and mycoses (154) 154
cephalosporins (148) 148
urinary tract infections (146) 146
aged, 80 and over (139) 139
drug therapy (139) 139
amikacin (135) 135
carbapenems (132) 132
antibiotic resistance (128) 128
ciprofloxacin (127) 127
medicine (127) 127
adolescent (126) 126
research article (125) 125
retrospective studies (124) 124
bacterial infections (123) 123
sepsis (122) 122
pediatrics (121) 121
pharmacokinetics (120) 120
clavulanic acid (119) 119
dosage and administration (118) 118
anti-bacterial agents - adverse effects (116) 116
case report (114) 114
piperacillin, tazobactam drug combination (114) 114
cephalosporins - pharmacology (113) 113
immunology (113) 113
nosocomial infections (113) 113
escherichia coli (112) 112
laboratories (112) 112
bacteremia (111) 111
bacterial pneumonia (111) 111
escherichia coli - drug effects (110) 110
internal medicine (110) 110
penicillanic acid - adverse effects (110) 110
piperacillin - adverse effects (110) 110
blood (109) 109
prospective studies (108) 108
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2668) 2668
Spanish (31) 31
Chinese (30) 30
German (29) 29
Japanese (27) 27
French (22) 22
Portuguese (15) 15
Italian (8) 8
Turkish (8) 8
Czech (3) 3
Korean (2) 2
Russian (2) 2
Dutch (1) 1
Hungarian (1) 1
Polish (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Évolution des consommations d’antibiotiques dans 115 établissements de santé, Ile-de-France, 2013–2017
by L’hériteau, F and Nkoumazok, B and Gaudichon, A and Astagneau, P
Médecine et maladies infectieuses, ISSN 0399-077X, 06/2019, Volume 49, Issue 4, pp. S56 - S56
Tazobactam
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial
by Harris, Patrick N. A and Tambyah, Paul A and Lye, David C and Mo, Yin and Lee, Tau H and Yilmaz, Mesut and Alenazi, Thamer H and Arabi, Yaseen and Falcone, Marco and Bassetti, Matteo and Righi, Elda and Rogers, Benjamin A and Kanj, Souha and Bhally, Hasan and Iredell, Jon and Mendelson, Marc and Boyles, Tom H and Looke, David and Miyakis, Spiros and Walls, Genevieve and Al Khamis, Mohammed and Zikri, Ahmed and Crowe, Amy and Ingram, Paul and Daneman, Nick and Griffin, Paul and Athan, Eugene and Lorenc, Penelope and Baker, Peter and Roberts, Leah and Beatson, Scott A and Peleg, Anton Y and Harris-Brown, Tiffany and Paterson, David L and Merino Trial Investigators and Australasian Soc Infect Dis Clinic and MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN) and for the MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN)
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2018, Volume 320, Issue 10, pp. 984 - 994
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Escherichia coli Infections - mortality | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Bacteremia - mortality | Ceftriaxone - pharmacology | Male | Cause of Death | Anti-Bacterial Agents - therapeutic use | Penicillanic Acid - therapeutic use | Adult | Female | Anti-Bacterial Agents - adverse effects | Meropenem | Penicillanic Acid - adverse effects | Thienamycins - adverse effects | Penicillanic Acid - analogs & derivatives | Thienamycins - therapeutic use | Escherichia coli Infections - drug therapy | Klebsiella Infections - drug therapy | Piperacillin, Tazobactam Drug Combination | Bacteremia - drug therapy | Piperacillin - adverse effects | Klebsiella Infections - mortality | Aged | Anti-Bacterial Agents - pharmacology | Piperacillin - therapeutic use | Klebsiella | Treatment outcome | Safety and security measures | Tazobactam | Escherichia coli | Patient outcomes | Analysis | Comparative analysis | Risk factors | Bacterial infections | Intravenous administration | Mortality | Clinical trials | Piperacillin-tazobactam | Infections | Ceftriaxone | Drug resistance | Patients | Side effects | Cephalosporins | E coli | Piperacillin | Drug therapy | Blood diseases | Blood culture | Carbapenems | Index Medicus | Abridged Index Medicus | Original Investigation | Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text A Population Pharmacokinetics and Pharmacodynamic Approach To Optimize Tazobactam Activity in Critically Ill Patients
by Kalaria, Shamir N and Gopalakrishnan, Mathangi and Heil, Emily L
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 03/2020, Volume 64, Issue 3
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Prospective Studies | Humans | Middle Aged | beta-Lactamase Inhibitors - blood | Critical Illness | Piperacillin, Tazobactam Drug Combination - pharmacokinetics | Male | beta-Lactamase Inhibitors - pharmacokinetics | Piperacillin, Tazobactam Drug Combination - blood | Tazobactam - blood | Tazobactam - pharmacokinetics | Female | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Ceftolozane/tazobactam: place in therapy
by Giacobbe, Daniele Roberto and Bassetti, Matteo and De Rosa, Francesco Giuseppe and Del Bono, Valerio and Grossi, Paolo Antonio and Menichetti, Francesco and Pea, Federico and Rossolini, Gian Maria and Tumbarello, Mario and Viale, Pierluigi and Viscoli, Claudio and ISGRI-SITA and ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva) and on behalf of ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva)
Expert review of anti-infective therapy, ISSN 1478-7210, 04/2018, Volume 16, Issue 4, pp. 307 - 320
tazobactam | ESBL | MDR | Antimicrobial resistance | ceftolozane | Pseudomonas | carbapenem-sparing | Enterobacteriaceae | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Off-Label Use | Pseudomonas aeruginosa - isolation & purification | Intraabdominal Infections - microbiology | Pseudomonas Infections - drug therapy | Enterobacteriaceae Infections - microbiology | Humans | Tazobactam - pharmacology | Enterobacteriaceae - isolation & purification | Cephalosporins - administration & dosage | Pseudomonas aeruginosa - drug effects | Pseudomonas Infections - microbiology | Urinary Tract Infections - drug therapy | Tazobactam - administration & dosage | Drug Resistance, Multiple, Bacterial | Enterobacteriaceae - drug effects | Urinary Tract Infections - microbiology | Anti-Bacterial Agents - pharmacology | Anti-Bacterial Agents - administration & dosage | Cephalosporins - pharmacology | Intraabdominal Infections - drug therapy | Enterobacteriaceae Infections - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Integrated Genome-Wide Analysis of an Isogenic Pair of Pseudomonas aeruginosa Clinical Isolates with Differential Antimicrobial Resistance to Ceftolozane/Tazobactam, Ceftazidime/Avibactam, and Piperacillin/Tazobactam
by Huang, Weihua and El Hamouche, Joelle and Wang, Guiqing and Smith, Melissa and Yin, Changhong and Dhand, Abhay and Dimitrova, Nevenka and Fallon, John T
International journal of molecular sciences, ISSN 1422-0067, 02/2020, Volume 21, Issue 3, p. 1026
Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Index Medicus | ceftazidime/avibactam (cza) | pseudomonas aeruginosa | piperacillin/tazobactam (p/t) | epigenetic profiling | antimicrobial resistance | ceftolozane/tazobactam (c/t) | rna sequencing (rnaseq) | whole-genome sequencing (wgs)
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Continuous infusion of ceftolozane/tazobactam is associated with a higher probability of target attainment in patients infected with Pseudomonas aeruginosa
by Pilmis, Benoît and Petitjean, Grégoire and Lesprit, Philippe and Lafaurie, Matthieu and El Helali, Najoua and Le Monnier, Alban and ATB PK PD Study Grp and on behalf the ATB PK/PD study group
European journal of clinical microbiology & infectious diseases, ISSN 0934-9723, 8/2019, Volume 38, Issue 8, pp. 1457 - 1461
Medical Microbiology | Biomedicine | Ceftolozane/tazobactam | Internal Medicine | Pseudomonas aeruginosa | Multidrug resistant | Pharmacokinetic/pharmacodynamic | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Prospective Studies | Drug Administration Schedule | Pseudomonas Infections - drug therapy | Humans | Middle Aged | Male | Pseudomonas aeruginosa - drug effects | Infusions, Intravenous - methods | Cephalosporins - therapeutic use | Microbial Sensitivity Tests | Tazobactam - pharmacokinetics | Anti-Bacterial Agents - therapeutic use | Tazobactam - therapeutic use | Drug Resistance, Multiple, Bacterial | Anti-Bacterial Agents - pharmacokinetics | Adult | Cephalosporins - pharmacokinetics | Female | Drug resistance in microorganisms | Mortality | Antimicrobial activity | Intravenous administration | Infections | Pharmacology | Drug resistance | Patients | Respiratory tract | Time dependence | Infusion | Tazobactam | Minimum inhibitory concentration | Respiratory tract diseases | Intravenous infusion | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Systematic review and metaanalysis of acute kidney injury associated with concomitant vancomycin and piperacillin/tazobactam
by Hammond, Drayton A and Smith, Melanie N and Li, Chenghui and Hayes, Sarah M and Lusardi, Katherine and Bookstaver, P. Brandon
Clinical infectious diseases, ISSN 1058-4838, 2017, Volume 64, Issue 5, pp. 666 - 674
Piperacillin-tazobactam | Vancomycin | Nephrotoxicity | Acute kidney injury | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Complications and side effects | Tazobactam | Piperacillin | Acute renal failure | Risk factors | Bacteria | Medical treatment | Kidney diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
by van Duin, David and Bonomo, Robert A
Clinical infectious diseases, ISSN 1058-4838, 07/2016, Volume 63, Issue 2, pp. 234 - 241
ceftazidime/avibactam | ceftolozane/tazobactam | multidrug resistance | Pseudomonas | Enterobacteriaceae | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Azabicyclo Compounds - administration & dosage | Humans | Ceftazidime - administration & dosage | Cephalosporins - pharmacokinetics | beta-Lactamase Inhibitors - administration & dosage | Azabicyclo Compounds - pharmacokinetics | Cephalosporins - administration & dosage | Drug Therapy, Combination | beta-Lactamase Inhibitors - pharmacokinetics | Ceftazidime - pharmacokinetics | Care and treatment | Pneumonia | Enterobacter | Antibiotics | Analysis | Bacterial pneumonia | Clinical trials | Dosage and administration | Research | Index Medicus | ceftazidime | tazobactam | Invited | avibactam | ceftolozane
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Impact of piperacillin/tazobactam on nephrotoxicity in patients with Gram-negative bacteraemia
by Hall, Ronald G and Yoo, Eunice and Faust, Andrew and Smith, Terri and Goodman, Edward and Mortensen, Eric M and Raza, Jaffar and Dehmami, Farbod and Alvarez, Carlos A
International journal of antimicrobial agents, ISSN 0924-8579, 03/2019, Volume 53, Issue 3, pp. 343 - 346
Gram-negative bacteraemia | Nephrotoxicity | Piperacillin/tazobactam | Acute kidney injury | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Humans | Middle Aged | Bacteremia - drug therapy | Gram-Negative Bacterial Infections - drug therapy | Male | beta-Lactamase Inhibitors - administration & dosage | Piperacillin, Tazobactam Drug Combination - adverse effects | Incidence | beta-Lactamase Inhibitors - adverse effects | Aged, 80 and over | Female | Acute Kidney Injury - chemically induced | Aged | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Anti-Bacterial Agents - administration & dosage | Piperacillin, Tazobactam Drug Combination - administration & dosage | Tazobactam | Analysis | Escherichia coli
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Paraostéoarthropathie neurogène : une cause rare de fièvre prolongée chez le paraplégique
by Maquet, J and Paricaud, K and Bories, E and Couture, G and Zabraniecki, L and Nougarolis, F and Beck, C and Aizel, G and Astudillo, L and Pugnet, G and Moulis, G and Sailler, L
La revue de medecine interne, ISSN 0248-8663, 06/2019, Volume 40, pp. A210 - A211
Tazobactam | Anticoagulants (Medicine) | Colchicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Un piège diagnostique : le syndrome de transillumination bilatérale aiguë de l’iris
by Giorgiutti, S and Krencker, D and Diallo, A.O and Ballonzoli, L and Poindron, V
La revue de medecine interne, ISSN 0248-8663, 06/2019, Volume 40, pp. A119 - A119
Tazobactam | Prednisone | Corticosteroids
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
by Abdul-Aziz, Mohd H and Lipman, Jeffrey and Akova, Murat and Bassetti, Matteo and De Waele, Jan J and Dimopoulos, George and Dulhunty, Joel and Kaukonen, Kirsi-Maija and Koulenti, Despoina and Martin, Claude and Montravers, Philippe and Rello, Jordi and Rhodes, Andrew and Starr, Therese and Wallis, Steven C and Roberts, Jason A and Paul, Sanjoy and Ribas, Antonio Margarit and De Crop, Luc and Spapen, Herbert and Wauters, Joost and Dugernier, Thierry and Jorens, Philippe and Dapper, Ilse and De Backer, Daniel and Taccone, Fabio S and Ruano, Laura and Afonso, Elsa and Alvarez-Lerma, Francisco and Gracia-Arnillas, Maria Pilar and Fernández, Francisco and Feijoo, Neus and Bardolet, Neus and Rovira, Assumpta and Garro, Pau and Colon, Diana and Castillo, Carlos and Fernado, Juan and Lopez, Maria Jesus and Fernandez, Jose Luis and Arribas, Ana Maria and Teja, Jose Luis and Ots, Elsa and Montejo, Juan Carlos and Catalan, Mercedes and Prieto, Isidro and Gonzalo, Gloria and Galvan, Beatriz and Blasco, Miguel Angel and Meyer, Estibaliz and Nogal, Frutos Del and Vidaur, Loreto and Sebastian, Rosa and Garde, Pila Marco and Velasco, Maria del Mar Martin and Crespo, Rafael Zaragoza and Esperatti, Mariano and Torres, Antoni and Baldesi, Olivier and Dupont, Herve and Mahjoub, Yazine and Lasocki, Sigismond and Constantin, Jean Michel and Payen, Jean François and Albanese, Jacques and Malledant, Yannick and Pottecher, Julien and Lefrant, Jean-Yves and Jaber, Samir and Joannes-Boyau, Olivier and Orban, Christophe and Ostermann, Marlies and McKenzie, Catherine and Berry, Willaim and Smith, John and Lei, Katie and Rubulotta, Francesca and Gordon, Anthony and Brett, Stephen and Stotz, Martin and Templeton, Maie and Ebm, Claudia and Moran, Carl and Pettilä, Ville and Xristodoulou, Aglaia and Theodorou, Vassiliki and Kouliatsis, Georgios and Sertaridou, Eleni and Anthopoulos, Georgios and Choutas, George and Rantis, Thanos and Karatzas, Stylianos and Balla, Margarita and Papanikolaou, Metaxia and Myrianthefs, Pavlos and Gavala, Alexandra and Fildisis, Georgios and Koutsoukou, Antonia and Kyriakopoulou, Magdalini and Petrochilou, Kalomoira and ... and DALI Study Grp and DALI Study Group
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 01/2016, Volume 71, Issue 1, pp. 196 - 207
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Intensive Care Units | Prospective Studies | Thienamycins - administration & dosage | Blood Chemical Analysis | Humans | Middle Aged | Thienamycins - pharmacokinetics | Critical Illness | Piperacillin - pharmacokinetics | Male | Treatment Outcome | Microbial Sensitivity Tests | Piperacillin - administration & dosage | Anti-Bacterial Agents - pharmacokinetics | Penicillanic Acid - pharmacokinetics | Female | Aged | Infusions, Intravenous | Anti-Bacterial Agents - administration & dosage | Penicillanic Acid - analogs & derivatives | Penicillanic Acid - administration & dosage | Intensive care | Pharmacology | Kinetics | Antibiotics | Patients | Clinical outcomes | Index Medicus | Life Sciences | Microbiology and Parasitology | Human health and pathology | Infectious diseases | Pharmaceutical sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights